Frequently Asked Questions
The market is segmented based on , By Products (Consumables and Accessories, Devices), Methods (Microscopic Identification, Fecal Identification, Immunological Techniques, Morphological Identification, Molecular Techniques, Rapid Diagnostic Tests (RDTs), Maldi-TOF MS, Others), Pathogen Type (Protozoan, Helminths, Arthropodes, Tapeworm, Ectoparast), Sample (Feces, Blood, Urine, Cerebrospinal Fluid (CSF), Serum and Plasma, Others), Stool Concentration and Preparation (Concentration Technique, Un-Concentration Technique), End User (Diagnostic Centers, Hospitals, Clinics, Ambulatory Surgical Centres, Others) – Industry Trends and Forecast to 2030.
.
The Global Parasitology Identification Market size was valued at USD 4092.15 USD Million in 2022.
The Global Parasitology Identification Market is projected to grow at a CAGR of 6% during the forecast period of 2023 to 2023.
The major players operating in the market include Abbott, BD, bioMérieux, Bruker, Quest Diagnostics, Akron Biotech, Thermo Fisher Scientific, altona Diagnostics, Biomerica, BioRad Laboratories, Creative Diagnostics, Luminex Corporation, Meridian Bioscience, RBiopharm AG, Shimadzu Corporation, Institut Virion/Serion, VWR International, Hardy Diagnostics, TECHLAB, AlphaTec, Medical Chemical Corporation.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
